We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.15,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting AgreementUnderwriting Agreement • April 2nd, 2013 • BioMed Realty Trust Inc • Real estate investment trusts • New York
Contract Type FiledApril 2nd, 2013 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”), Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Morgan Stanley and Raymond James are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 15,000,000 shares (the “Firm Securities”) of the Company's common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 2,250,000 additional shares of Common Stock (the “Optional Securities”), sub
12,700,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting AgreementUnderwriting Agreement • February 19th, 2013 • BioMed Realty Trust Inc • Real estate investment trusts • New York
Contract Type FiledFebruary 19th, 2013 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”), Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Morgan Stanley and Raymond James are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 12,700,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 1,905,000 additional shares of Common Stock (the “Optional Securities”), sub
BioMed Realty, L.P. (a Maryland limited partnership) As Issuer BioMed Realty Trust, Inc. (a Maryland corporation) As Guarantor $400,000,000 3.85% Senior Notes due 2016 Underwriting AgreementUnderwriting Agreement • March 29th, 2011 • BioMed Realty L P • Real estate • New York
Contract Type FiledMarch 29th, 2011 Company Industry JurisdictionBioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership”), and BioMed Realty Trust, Inc., a Maryland corporation (the “Company” and, together with the Operating Partnership, the “Transaction Entities”), each confirms its agreement with Wells Fargo Securities, LLC (“Wells Fargo Securities”), KeyBanc Capital Markets Inc. (“KeyBanc”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Wells Fargo Securities, KeyBanc and Morgan Stanley are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Operating Partnership and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth on Schedule I of $400,000,000 aggregate principal amount of 3.85% Senior Notes due 2016 (the “Offered Securities”), subject to the terms and conditions set forth below. The Offered Securities are to be issue
15,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • September 29th, 2010 • BioMed Realty Trust Inc • Real estate investment trusts • New York
Contract Type FiledSeptember 29th, 2010 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Wells Fargo Securities, LLC (“Wells Fargo Securities”), Raymond James & Associates, Inc. (“Raymond James”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Wells Fargo Securities, Raymond James, Morgan Stanley and UBS are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 15,000,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an opt
11,500,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • April 19th, 2010 • BioMed Realty Trust Inc • Real estate investment trusts • New York
Contract Type FiledApril 19th, 2010 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”), Wells Fargo Securities, LLC (“Wells”) and KeyBanc Capital Markets Inc. (“KeyBanc”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James, Morgan Stanley, UBS, Wells and KeyBanc are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 11,500,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and no
16,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • May 18th, 2009 • BioMed Realty Trust Inc • Real estate investment trusts • Florida
Contract Type FiledMay 18th, 2009 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”), KeyBanc Capital Markets Inc. (“KeyBanc”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”), Wachovia Capital Markets, LLC (“Wachovia”) and Credit Suisse Securities (USA) LLC (“Credit Suisse”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James, KeyBanc, Morgan Stanley, UBS, Wachovia and Credit Suisse are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 16,000,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with res
5,700,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • April 22nd, 2008 • BioMed Realty Trust Inc • Real estate investment trusts • Florida
Contract Type FiledApril 22nd, 2008 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James is acting as representative (the “Representative”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 5,700,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 855,000 additional shares of Common Stock (the “Optional Securities”), subject to the terms and conditions set forth below. The Firm Securities
6,950,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • August 21st, 2006 • BioMed Realty Trust Inc • Real estate investment trusts • Florida
Contract Type FiledAugust 21st, 2006 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James is acting as representative (the “Representative”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 6,950,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 1,042,500 additional shares of Common Stock (the “Optional Securities”), subject to the terms and conditions set forth below. The Firm Securitie
9,075,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementUnderwriting Agreement • May 16th, 2006 • BioMed Realty Trust Inc • Real estate investment trusts • Florida
Contract Type FiledMay 16th, 2006 Company Industry JurisdictionBioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James is acting as representative (the “Representative”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 9,075,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 1,361,250 additional shares of Common Stock (the “Optional Securities”), subject to the terms and conditions set forth below. The Firm Securitie